Profiel
Mark K.
H.
Lee is currently the Vice President-Corporate Finance & Development at Hutchison MediPharma Ltd. He previously worked as a Licensing Associate at Bristol Myers Squibb Co., a Principal at Genzyme Corp.
and Nanosphere, Inc., and a Vice President at Credit Suisse First Boston Corp.
He also worked as a Principal at AstraZeneca LP.
Mr. Lee received his undergraduate degree from University College London and his MBA from MIT Sloan School of Management.
Actieve functies van Mark K. H. Lee
| Bedrijven | Functie | Begin |
|---|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Discovers and develops innovative human therapeutics | Financieel Directeur/CFO | 24-03-2010 |
Eerdere bekende functies van Mark K. H. Lee
| Bedrijven | Functie | Einde |
|---|---|---|
Credit Suisse First Boston Corp.
Credit Suisse First Boston Corp. Real Estate Investment TrustsFinance Real Estate Investment Trusts | Corporate Officer/Principal | - |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| NANOSPHERE, INC. | Corporate Officer/Principal | - |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Corporate Officer/Principal | - |
Opleiding van Mark K. H. Lee
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Nanosphere, Inc.
Nanosphere, Inc. Medical SpecialtiesHealth Technology Develops molecular testing systems | Health Technology |
Credit Suisse First Boston Corp.
Credit Suisse First Boston Corp. Real Estate Investment TrustsFinance Real Estate Investment Trusts | Finance |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Discovers and develops innovative human therapeutics | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















